
An update from Arcadia Biosciences ( ($RKDA) ) is now available. At Arcadia Biosciences’ Annual Meeting held on September 10, 2026, stockholders representing about 52.3% of outstanding common shares participated
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| RKDA | Arcadia Biosciences | 0.22 | -3.55 | -94.22% |
| Name | Price | % Change | |
|---|---|---|---|
| $0.22 | -94.22% |

An update from Arcadia Biosciences ( ($RKDA) ) is now available. At Arcadia Biosciences’ Annual Meeting held on September 10, 2026, stockholders representing about 52.3% of outstanding common shares participated

Arcadia Biosciences ( ($RKDA) ) just unveiled an announcement. On August 31, 2026, Arcadia Biosciences disclosed that Nasdaq had notified the company its stockholders’ equity, reported at $633,000 as of

Arcadia Biosciences ( ($RKDA) ) has shared an update. On July 1, 2026, Arcadia Biosciences’ board and compensation committee approved a discretionary cash bonus of $169,000 for chief executive and

16:34 EDT Arcadia Biosciences (RKDA) files to sell 11.92M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try

Arcadia Biosciences ( ($RKDA) ) has issued an update. On June 11, 2026, Arcadia Biosciences entered into a securities purchase agreement with an institutional accredited investor for a $4 million

Arcadia Biosciences (RKDA) announced that it has entered into securities purchase agreements for the purchase and sale of 3,883,496 shares of its common stock , Series A-1 preferred investment options

An update from Arcadia Biosciences ( ($RKDA) ) is now available. On February 4, 2026, Arcadia Biosciences, Inc. announced that directors Albert D. Bolles, Ph.D., and Deborah Carosella resigned from

06:09 EST Arcadia Biosciences (RKDA) files to sell 1.67M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try

Arcadia Biosciences ( ($RKDA) ) has provided an announcement. On January 9, 2026, Arcadia Biosciences entered into inducement agreements with certain investors to immediately exercise previously issued preferred investment options

Arcadia Biosciences ( ($RKDA) ) has issued an announcement. On January 9, 2026, Arcadia Biosciences entered into inducement agreements with certain investors to immediately exercise previously issued preferred investment options
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Apr 1, 2027TBA | $1.32M | ― | ― | 0.02 | -0.03 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.